Nebenwirkungen · Herceptin
Herceptin 150 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 13–14
HOS-090923 · Präparat HOS-084155
13 System organ class Adverse reaction Frequency Pain in extremity Common Renal and urinary Renal disorder Common disorders Glomerulonephritis membranous Not known Glomerulonephropathy Not known Renal failure Not known Pregnancy, puerperium Oligohydramnios Not known and perinatal conditions Renal hypoplasia Not known Pulmonary hypoplasia Not known Reproductive system and Breast inflammation/mastitis Common breast disorders General disorders and Asthenia Very common administration site Chest pain Very common conditions Chills Very common Fatigue Very common Influenza-like symptoms Very common Infusion related reaction Very common Pain Very common Pyrexia Very common Mucosal inflammation Very common Peripheral oedema Very common Malaise Common Oedema Common Injury, poisoning and Contusion Common procedural complications + Denotes adverse reactions that have been reported in association with a fatal outcome. 1 Denotes adverse reactions that are reported largely in association with Infusion-related reactions. Specific percentages for these are not available. * Observed with combination therapy following anthracyclines and combined with taxanes
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-25T17:43:00Z · SHA-256 4737cd7c26cd2805fc40be61983542b3a3127abbce7e3ca6ebc3b5c0895dda53 · Passage 3287a12c7fd8d0ae18a521ebc797666cf08c3ac5c4d0f33e496b421187c1bce8 · Zeichen 12039–14555 im Abschnitt